Herceptin Hylecta 10000 U/5mL
Trastuzumab and hyaluronidase-oysk · INJECTION, SOLUTION · Genentech, Inc.
Herceptin Hylecta is a injection, solution containing trastuzumab and hyaluronidase-oysk at 10000 U/5mL, taken subcutaneous. Manufactured by Genentech, Inc..
Key Facts
- Brand Name
- Herceptin Hylecta
- Generic Name
- Trastuzumab and hyaluronidase-oysk
- NDC Code (Product)
50242-077- Manufacturer
- Genentech, Inc.
- Strength
- 10000 U/5mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761106
- Drug Class
- Endoglycosidase [EPC]; HER2/neu Receptor Antagonist [EPC]
- Marketing Start
- 02/28/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is Herceptin Hylecta used for?
Herceptin Hylecta contains Trastuzumab and hyaluronidase-oysk. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Herceptin Hylecta a controlled substance?
Herceptin Hylecta is not classified as a controlled substance by the DEA.
What is the generic name for Herceptin Hylecta?
The generic name for Herceptin Hylecta is Trastuzumab and hyaluronidase-oysk. There are no other listed brand versions of Trastuzumab and hyaluronidase-oysk.
What is the NDC code for Herceptin Hylecta 10000 U/5mL?
The NDC (National Drug Code) for Herceptin Hylecta 10000 U/5mL is 50242-077, listed by Genentech, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)